Early versus deferred androgen suppression in the treatment of advanced prostatic cancer.

Early versus deferred androgen suppression in the treatment of advanced prostatic cancer.

Item
http://www.wikidata.org/entity/Q32064496
Sulforaphane destabilizes the androgen receptor in prostate cancer cells by inactivating histone deacetylase 6A system for rating the stability and strength of medical evidenceEnzalutamide in metastatic prostate cancer before chemotherapy.SEOM clinical guidelines for the treatment of metastatic prostate cancerRisk stratification in the hormonal treatment of patients with prostate cancerBiological profile of erucin: a new promising anticancer agent from cruciferous vegetables.What should urologists know about evidence-based medicine?Endocrine therapy in prostate cancer: time for reappraisal of risks, benefits and cost-effectiveness?Leuprolide acetate 1-, 3- and 6-monthly depot formulations in androgen deprivation therapy for prostate cancer in nine European countries: evidence review and economic evaluation.Trends and racial differences in the use of androgen deprivation therapy for metastatic prostate cancer.Uroncor consensus statement: Management of biochemical recurrence after radical radiotherapy for prostate cancer: From biochemical failure to castration resistance.The effect of salvage therapy on survival in a longitudinal study with treatment by indication.Less advanced disease at initiation of salvage androgen deprivation therapy is associated with decreased mortality following biochemical failure post-salvage radiation therapy.
P2860

Early versus deferred androgen suppression in the treatment of advanced prostatic cancer.

Item
http://www.wikidata.org/entity/Q32064496
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Early versus deferred androgen suppression in the treatment of advanced prostatic cancer.
@ast
Early versus deferred androgen suppression in the treatment of advanced prostatic cancer.
@en
type
label
Early versus deferred androgen suppression in the treatment of advanced prostatic cancer.
@ast
Early versus deferred androgen suppression in the treatment of advanced prostatic cancer.
@en
prefLabel
Early versus deferred androgen suppression in the treatment of advanced prostatic cancer.
@ast
Early versus deferred androgen suppression in the treatment of advanced prostatic cancer.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P577
P698
P356
P1433
P1476
Early versus deferred androgen suppression in the treatment of advanced prostatic cancer.
@en
P2093
P2860
P304
P31
P356
P433
P577
P698